Directory
>
Alan Musso
Alan Musso
Chief Financial Officer | Fulcrum Therapeutics
Raleigh, North Carolina, United States
Alan Musso
Summary
Alan Musso is a seasoned Chief Financial Officer and board member specializing in the biopharma and life sciences sectors. With a robust background in finance and accounting, he has navigated complex financial landscapes across various organizations, including startups and established firms. Alan's experience spans over three decades, during which he has held leadership roles in notable companies such as Pfizer and KPMG. His expertise encompasses financial analysis, investor relations, and strategic partnerships, making him a key player in driving business growth. Alan is passionate about the intersection of finance and biotechnology, aiming to leverage financial strategies for innovative healthcare solutions. He holds a Master's in International Business and Finance from Thunderbird School of Global Management and a Bachelor's in Accounting from Saint Mary's College of California. Residing in Raleigh, North Carolina, he is well-positioned to contribute to the evolving biopharma landscape.
Alan Musso
Work Experience
Chief Financial Officer at
Fulcrum Therapeutics
August 2023 - Present
Board Member and Advisor, Biopharma & Life Sciences at
Self-Employed
October 2022 - August 2023
CFO at ReViral at
ReViral
October 2019 - September 2022
CFO at
Peloton Therapeutics
September 2018 - September 2019
CFO at
Bellicum Pharmaceuticals, Inc.
November 2014 - August 2018
CFO at
Targacept, Inc.
February 2002 - November 2014
CFO at
Osiris Therapeutics
January 2001 - January 2002
CFO at
Cato Research
January 1997 - January 2001
Director of Finance at
Duramed Pharmaceuticals
January 1995 - March 1997
Finance at
Pfizer
January 1989 - January 1995
Professional - Audit Dept at
KPMG US
January 1984 - January 1987
Alan Musso
Education
Thunderbird School of Global Management, Mim
January 2008 - January 2008
Saint Mary's College of California, Bs
January 1980 - January 1984
Frequently Asked Questions about Alan Musso
What is Alan Musso email address?
Alan Musso's primary email address is ******@fulcrumtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Alan Musso work for?
Alan Musso is a Chief Financial Officer at Fulcrum Therapeutics, a company specializing in Commercial physical research.
Where Alan Musso graduated from?
Alan Musso holds a degree in International Business And Finance from Thunderbird School of Global Management.
How can I directly contact Alan Musso?
To contact Alan Musso directly, you can use the email address ******@fulcrumtx.com. Complete contact information is available upon registration with Muraena.
Who is Alan Musso?
Alan Musso is a seasoned Chief Financial Officer and board member specializing in the biopharma and life sciences sectors. With a robust background in finance and accounting, he has navigated complex financial landscapes across various organizations, including startups and established firms. Alan's experience spans over three decades, during which he has held leadership roles in notable companies such as Pfizer and KPMG. His expertise encompasses financial analysis, investor relations, and strategic partnerships, making him a key player in driving business growth. Alan is passionate about the intersection of finance and biotechnology, aiming to leverage financial strategies for innovative healthcare solutions. He holds a Master's in International Business and Finance from Thunderbird School of Global Management and a Bachelor's in Accounting from Saint Mary's College of California. Residing in Raleigh, North Carolina, he is well-positioned to contribute to the evolving biopharma landscape.
Alan`s contact details
******@fulcrumtx.com
******@reviral.co.uk
Colleagues
Vice President, Head of Talent Acquisition & People Experience
Vice President, Head of Strategy & Program Lead
Chief Executive Officer
SVP, Head of Medical Affairs
Vice President
Vice President Drug Substance Process Development
Vice President, Head of Medicinal Chemistry
Chief Scientific Officer and Head of Technical Operations
Vice President Drug Safety & Pharmacovigilance
Chief Operating Officer